Filing Details

Accession Number:
0001099910-12-000184
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-23 17:14:32
Reporting Period:
2012-07-19
Filing Date:
2012-07-23
Accepted Time:
2012-07-23 17:14:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1126234 Newlink Genetics Corp NLNK Pharmaceutical Preparations (2834) 421491350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512113 Jr. J. Charles Link C/O Newlink Genetics Corp.
2503 South Loop Dr., Suite 5100
Ames IA 50010
Chairman Of The Board And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-19 139 $13.54 139 No 4 P Indirect By Spouse's IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse's IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect By Spouse
Common Stock 1,223,487 Direct
Footnotes
  1. The spouse of the reporting person's purchase of Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 139 shares, with the reporting person's sale of shares of Issuer's common stock at the highest price of $15.9852 per share on June 20, 2012. The reporting person has paid to Issuer, upon settlement of the sale, $339.89 representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.